Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Itzel

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|January 23, 2021
p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury ModelLaura Elisa Buitrago-Molina, Silke Marhenke, Diana Becker, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 29, 2019
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cellsFlorian P Reiter, Gerald Denk, Andreas Ziesch, et al.
The Journal of Clinical Investigation|January 31, 2020
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancerPeter Dietrich, Laura Wormser, Valerie Fritz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2014
Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolitesWitigo von Schönfels, Eleonora Patsenker, René Fahrner, et al.
Cells|March 8, 2020
BMP-9 Modulates the Hepatic Responses to LPSHaristi Gaitantzi, Julius Karch, Lena Germann, et al.
Molecular Oncology|November 8, 2021
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venuesAlexander Scheiter, Katja Evert, Lucas Reibenspies, et al.
Cell Metabolism|August 13, 2013
DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgeryMarkus Ahrens, Ole Ammerpohl, Witigo von Schönfels, et al.
Gastroenterology|June 19, 2016
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From PatientsAndreas Teufel, Timo Itzel, Wiebke Erhart, et al.
Oncology Letters|August 27, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumabIsaac Rodriguez, Abhinay Vellala, Timo Itzel, et al.
Gut|January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Gastroenterology and Hepatology|January 23, 2021
p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury ModelLaura Elisa Buitrago-Molina, Silke Marhenke, Diana Becker, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 29, 2019
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cellsFlorian P Reiter, Gerald Denk, Andreas Ziesch, et al.
The Journal of Clinical Investigation|January 31, 2020
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancerPeter Dietrich, Laura Wormser, Valerie Fritz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2014
Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolitesWitigo von Schönfels, Eleonora Patsenker, René Fahrner, et al.
Cells|March 8, 2020
BMP-9 Modulates the Hepatic Responses to LPSHaristi Gaitantzi, Julius Karch, Lena Germann, et al.
Molecular Oncology|November 8, 2021
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venuesAlexander Scheiter, Katja Evert, Lucas Reibenspies, et al.
Cell Metabolism|August 13, 2013
DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgeryMarkus Ahrens, Ole Ammerpohl, Witigo von Schönfels, et al.
Gastroenterology|June 19, 2016
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From PatientsAndreas Teufel, Timo Itzel, Wiebke Erhart, et al.
Oncology Letters|August 27, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumabIsaac Rodriguez, Abhinay Vellala, Timo Itzel, et al.
Gut|January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Pageof 4